1.
Dana Martinez M, Gonzalez-Castellanos E, Barros-Centeno MF, Correa L, Guantay CD, Serra HM, et al. Bevacizumab intravítreo como tratamiento de maculopatías miópicas neovasculares. Rev. Methodo [Internet]. 2017 Jun. 30 [cited 2025 Dec. 5];2(2):55-8. Available from: https://revistas.bibdigital.uccor.edu.ar/index.php/method/article/view/1357